University of Münster
CRIS@UM
DE | EN

Lessons From the EThIGII Trial: Proper Putative Benefit Assessment of Low- Molecular-Weight Heparin Treatment in M2/ANXA5 Haplotype Carriers

Rogenhofer N, Markoff A, Wagner A, Klein HG, Petroff D, Schleussner E, Thaler CJ

Research article (journal) | Peer reviewed

Details about the publication

Journal: Clinical and Applied Thrombosis/Hemostasis
Volume: 2016
Status: online first
Release year: 2016 (14/07/2016)
Language in which the publication is written: English
DOI: 10.1177/1076029616658117
Link to the full text: http://cat.sagepub.com/cgi/reprint/1076029616658117v1.pdf?ijkey=AppD688vEVNzgbi&keytype=finite

Authors from the University of Münster

Markov, Arseni
Institute of Human Genetics